These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 21762313

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.
    Tullo V, Valguarnera F, Barbanti P, Cortelli P, Sette G, Allais G, d'Onofrio F, Curone M, Zava D, Pezzola D, Benedetto C, Frediani F, Bussone G.
    Cephalalgia; 2014 May; 34(6):434-45. PubMed ID: 24363238
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.
    Allais G, Rolando S, De Lorenzo C, Benedetto C.
    Expert Rev Neurother; 2014 Aug; 14(8):867-77. PubMed ID: 25056381
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A, Leonardi M, Bussone G, D'Amico D.
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.
    Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Fierro B, Brighina F.
    J Headache Pain; 2012 Jul; 13(5):401-6. PubMed ID: 22592864
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Examining the interrelationship of migraine onset, duration, and time to treatment.
    Landy SH, Runken MC, Bell CF, Higbie RL, Haskins LS.
    Headache; 2012 Mar; 52(3):363-73. PubMed ID: 22077159
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Goldstein J, Tiseo PT, Albert KS, Li C, Sikes CR.
    Headache; 2006 Mar; 46(7):1142-50. PubMed ID: 16866718
    [Abstract] [Full Text] [Related]

  • 39. Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
    Cady RK, Freitag FG, Mathew NT, Elkind AH, Mao L, Fisher AC, Biondi DM, Finlayson G, Greenberg SJ, Hulihan JF.
    Headache; 2009 Mar; 49(3):350-63. PubMed ID: 19220503
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.